U.K.-based gynaecological health startup Daye has completed a £10 million funding round and announced the launch of its vaginal microbiome screening tests that can detect infections and pathogens which are linked to STIs and vaginal infections, as well as fertility, pregnancy and IVF complications.
Daye Launches World’s First Tampon-Based At-Home Screening Kit, Raises $11.4 Million In Latest Funding Round
